Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic Cholangiocarcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Cholangiocarcinoma

Interventions

DIAGNOSTIC_TEST

Proteomic profiling

Proteomic profiling as a diagnostic tool in the face of suspected extrahepatic cholangiocarcinoma stenosis

Trial Locations (1)

CHU Bordeaux, Pessac

All Listed Sponsors

collaborator

University of Bordeaux

OTHER

collaborator

Plateforme Oncoprot (TBMCore 3427 - US005, Bordeaux Biologie Santé)

UNKNOWN

lead

University Hospital, Bordeaux

OTHER

NCT06780553 - Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic Cholangiocarcinoma | Biotech Hunter | Biotech Hunter